» Articles » PMID: 21234411

Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection

Overview
Journal Parkinsons Dis
Publisher Wiley
Date 2011 Jan 15
PMID 21234411
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondria are vitally important organelles involved in an array of functions. The most notable is their prominent role in energy metabolism, where they generate over 90% of our cellular energy in the form of ATP through oxidative phosphorylation. Mitochondria are involved in various other processes including the regulation of calcium homeostasis and stress response. Mitochondrial complex I impairment and subsequent oxidative stress have been identified as modulators of cell death in experimental models of Parkinson's disease (PD). Identification of specific genes which are involved in the rare familial forms of PD has further augmented the understanding and elevated the role mitochondrial dysfunction is thought to have in disease pathogenesis. This paper provides a review of the role mitochondria may play in idiopathic PD through the study of experimental models and how genetic mutations influence mitochondrial activity. Recent attempts at providing neuroprotection by targeting mitochondria are described and their progress assessed.

Citing Articles

Type 2 diabetes microenvironment promotes the development of Parkinson's disease by activating microglial cell inflammation.

Zhang B, Song C, Tang X, Tian M, Liu Y, Yan Z Front Cell Dev Biol. 2024; 12:1422746.

PMID: 39050892 PMC: 11266050. DOI: 10.3389/fcell.2024.1422746.


-Associated Parkinson's Disease Is a Distinct Entity.

Skrahin A, Horowitz M, Istaiti M, Skrahina V, Lukas J, Yahalom G Int J Mol Sci. 2024; 25(13).

PMID: 39000225 PMC: 11241486. DOI: 10.3390/ijms25137102.


Polyphenols Have a Preventive Effect on Parkinson's Disease through the Activation of the Nrf2-ARE Pathway.

Yasuda Y, Tokumatsu T, Ueda C, Sakai M, Sasaki Y, Norikura T Nutrients. 2024; 16(13).

PMID: 38999824 PMC: 11243082. DOI: 10.3390/nu16132076.


Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Opportunities.

Clemente-Suarez V, Redondo-Florez L, Beltran-Velasco A, Ramos-Campo D, Belinchon-deMiguel P, Martinez-Guardado I Biomedicines. 2023; 11(9).

PMID: 37760929 PMC: 10526226. DOI: 10.3390/biomedicines11092488.


Primary cilia and SHH signaling impairments in human and mouse models of Parkinson's disease.

Schmidt S, Luecken M, Trumbach D, Hembach S, Niedermeier K, Wenck N Nat Commun. 2022; 13(1):4819.

PMID: 35974013 PMC: 9380673. DOI: 10.1038/s41467-022-32229-9.


References
1.
Klivenyi P, Ferrante R, Matthews R, Bogdanov M, Klein A, Andreassen O . Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med. 1999; 5(3):347-50. DOI: 10.1038/6568. View

2.
Devi L, Raghavendran V, Prabhu B, Avadhani N, Anandatheerthavarada H . Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem. 2008; 283(14):9089-100. PMC: 2431021. DOI: 10.1074/jbc.M710012200. View

3.
Przedborski S, Kostic V, Jackson-Lewis V, Naini A, Simonetti S, Fahn S . Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J Neurosci. 1992; 12(5):1658-67. PMC: 6575882. View

4.
Polymeropoulos M, Lavedan C, Leroy E, Ide S, Dehejia A, Dutra A . Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997; 276(5321):2045-7. DOI: 10.1126/science.276.5321.2045. View

5.
Klaidman L, Adams Jr J, Leung A, Kim S, Cadenas E . Redox cycling of MPP+: evidence for a new mechanism involving hydride transfer with xanthine oxidase, aldehyde dehydrogenase, and lipoamide dehydrogenase. Free Radic Biol Med. 1993; 15(2):169-79. DOI: 10.1016/0891-5849(93)90056-z. View